Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Journal Information
Full Title: Ann Surg Oncol
Abbreviation: Ann Surg Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: General Surgery
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Thorvardur R. Halfdanarson: served on the consulting/advisory board for Ipsen, TerSera, ScioScientific, Curium, Advanced Accelerator Applications (a Novartis company), Terumo, ITM Isotopen Technologien Muenchen, and Crinetics. Dr Halfdanardson received research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Basilea, Turnstone Biologics, and Agios. The remaining authors have no conflicts of interest."
"Financial support was provided internally by the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and the Mayo Clinic Department of Surgery."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025